AES Press Releases
NIHON KOHDEN AMERICA ANNOUNCES THE AUCTION OF ITS LATEST EEG TECHNOLOGY
IN SUPPORT OF THE AES LENNOX AND LOMBROSO TRUST FUND AND SUSAN SPENCER RESEARCH FUND
Foothill Ranch, Calif., November 30, 2012 — Nihon Kohden America, Inc. today announced that proceeds from the auction of its new EEG-1200A EEG Diagnostic and Monitoring system will be presented to the American Epilepsy Society (AES) in support of the Lennox and Lombroso Trust and the Susan Spencer Research Fund. A check presentation ceremony will take place at 12:00PM December 1st at the AES annual scientific meeting in San Diego. The $27,684.00 check will presented to Dennis D. Spencer, M.D., who chairs the AES Research Fund Development Committee and will be receiving the funds on behalf of the society.
Kathy Hart, V.P. of NKA’s Neurology Business says, “For over 60 years Nihon Kohden has been committed to the introduction of technological advancements to improve the diagnosis and care for people with epilepsy. For the fourth year in a row, Nihon Kohden is proud to provide 100% of the proceeds from the EEG-1200A auction to the Lennox and Lombroso Trust for Epilepsy Research and Training in addition to the Susan S. Spencer Clinical Research Training Fellowship in Epilepsy to augment support of the next generation’s promising new scientists and research in Epilepsy. We are honored to continue this legacy of support.”
"Support for research and training is critical to our search to find new discoveries and better ways to understand, treat and care for people with epilepsy,” said Frances Jensen, president American Epilepsy Society. “Having partners like Nihon Kohden who have consistently supported AES through this unique auction is vital in helping AES continue to seek the answers and work toward a world that is seizure free.”
About Nihon Kohden America
Nihon Kohden America was founded in 1979 as a wholly owned subsidiary of Nihon Kohden Corporation, Japan (founded in 1951). Nihon Kohden is a market leader in Patient Monitoring, Sleep Assessment, Neurology and Cardiology instrumentation. Our products are distributed to hospitals, physician’s practices, mobile services, and outpatient and surgery centers throughout North America. For more than 60 years, healthcare providers worldwide have relied on the quality and reliability of Nihon Kohden’s comprehensive and innovative line of neuro-diagnostic and –monitoring instrumentation to aid in the diagnosis, information and treatment of their patients.
Nihon Kohden’s long legacy in EEG diagnostics and monitoring continues with the EEG-1200 that combines EEG, Long Term Epilepsy, cEEG ICU Monitoring and Sleep Testing for the most flexible and comprehensive recording system available today. Our library of 32-256 channel amplifiers and AirEEG wireless technology offer superior signal quality and the highest recording specifications for discrete localization. The EEG-1200A system features a LAN connected, IP adjustable input converter for all amplifiers providing more configuration flexibility independent of the PC platform. Our MPEG4 digital video and audio software offers impressive time resolution playback of 1/30 second, full motion video as well as the ability to edit EEG and video during recording over the network. NeuroWorkbench™, the core integrator of Nihon Kohden’s Neurology portfolio of IOM, EMG and EEG systems is the common interface for exam scheduling, protocol administration and data management improving workflow and access to clinical data and records. More information about Nihon Kohden and our EEG-1200A technology can be found at www.nkusa.com.
About the Lennox and Lombroso Trust for Epilepsy Research & Training and the Susan S. Spencer Clinical Research Training Fellowship in Epilepsy
AES is the world's leading organization for professional training in Epilepsy treatment and research. AES has an ongoing commitment to education and research, and has devoted a significant portion of its operating income to support them. Importantly, AES has emphasized basic and clinical research opportunities for fellows and junior faculty at critical starting points in their careers, and this has been accomplished via peer-reviewed grants in collaboration with the Epilepsy Foundation. Indeed, these seed funds have supported individuals who are now leaders in the field, and continue to attract the best academicians to our field.
The role of AES in assuring excellent research, training, and clinical care has become ever more important as support from the National Institutes of Health and industry dwindles. We can no longer rely solely on others to invest in the future of our next generation and must build from within to create a secure foundation for epilepsy Education and Research. To invigorate our Society’s efforts for Research support, the AES leadership has chosen the newly created Lennox and Lombroso Trust for Research and Training as a key entity for growth. Current assets of the Trust approach $2.5 million, providing about $75,000 in yearly support for research and training. Our long term goal is to enable our endowment to provide an annual $300,000 grants program. Thus, the current level of endowment must increase fourfold to $10 million.
The newly created Susan S. Spencer Clinical Research Training Fellowship in Epilepsy is a two-year fellowship to support clinical research training in the field of epilepsy. The fellowship is supported by the AAN Foundation, the American Epilepsy Society, and the Epilepsy Foundation. Each fellowship consists of a commitment of $55,000 per year for two years, plus $10,000 per year for tuition to support formal education in clinical research methodology at the applicant’s institution or elsewhere.
Times are changing for all of us, and our Society is adapting to these changes with a solid plan for the future of our members and our field. What will never change is the Society’s commitment to epilepsy and to excellence.
Read more: http://www.aesnet.org
203.389.5223 - email@example.com